NCT05164744View on ClinicalTrials.gov

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

RecruitingOBSERVATIONAL
Enrollment

510

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 30, 2026

Study Completion Date

July 30, 2026

Conditions
COVID-19 PneumoniaCOVID-19COVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress SyndromeCOVID-19 Lower Respiratory InfectionCOVID-19 Acute BronchitisCoronavirus Disease 2019
Interventions
DIAGNOSTIC_TEST

Cardiac MRI

Patients participate in an NIH funded cardiac MRI to assess their symptoms.

DIAGNOSTIC_TEST

Echocardiogram

Patients participate in an NIH funded cardiac echocardiogram to assess their symptoms.

DIAGNOSTIC_TEST

6-minute walk test

Patients participate in a 6-minute walk test to assess their symptoms.

DIAGNOSTIC_TEST

Questionnaire

Patients answer a survey-based questionnaire to assess their symptoms.

Trial Locations (3)

10021

RECRUITING

New York Presbyterian Queens, New York

RECRUITING

Weill Cornell Medicine/New-York Presbyterian Hospital, New York

11215-3609

RECRUITING

New York Presbyterian-Brooklyn Methodist Hospital, Brooklyn

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Weill Medical College of Cornell University

OTHER